Literature DB >> 27423618

A family with hereditary diffuse leukoencephalopathy with spheroids caused by a novel c.2442+2T>C mutation in the CSF1R gene.

Ito Kawakami1, Eizo Iseki2, Koji Kasanuki3, Michiko Minegishi4, Kiyoshi Sato4, Hiroyuki Hino5, Katsuhiko Shibuya5, Kohshiro Fujisawa5, Shinji Higashi6, Haruhiko Akiyama6, Akiko Furuta7, Masashi Takanashi8, Yuanzhe Li8, Nobutaka Hattori8, Yoshio Mitsuyama9, Heii Arai7.   

Abstract

Clinical phenotypes of hereditary diffuse leukoencephalopathy with spheroids (HDLS), a familial progressive neurodegenerative disorder affecting the white matter of the brain, are heterogenous and may include behavioral and personality changes, memory impairment, parkinsonism, seizure, and spasticity. Thus, HDLS is frequently unrecognized and misdiagnosed. Heterozygous mutations located within the kinase domain of the gene encoding the colony-stimulating factor 1 receptor (CSF1R), a cell surface receptor with key roles in development and innate immunity, have been shown in HDLS. These different gene mutations may be related to the various clinical phenotypes. We report here a newly identified family with HDLS harboring a mutation in the CSF1R gene. We examined clinical and neuropathological features in three members of this family. These patients presented with affective incontinence, memory impairment, and executive dysfunction at onset, and revealed nonfluent aphasia, parkinsonism, and seizure as the disease progressed. We identified a novel CSF1R splice site mutation (c.2442+2T>C) in intron 18 for two of the patients. MRI of these patients revealed progressive, frontotemporal-predominant, confluent leukoencephalopathy. We also observed severe myelin loss, axonal degeneration, and abundant axonal spheroids, astrocytes, and microglia in the cerebral white matter, consistent with HDLS neuropathological features. Additionally, we identified atypical neuropathological findings for HDLS, including neuronal loss and gliosis with ballooned neurons and central chromatolysis in the frontal cortex and hippocampus. This report provides further evidence for the clinical and neuropathological heterogeneity of HDLS.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Axonal spheroid; CSF1R; HDLS; Leukoencephalopathy

Mesh:

Substances:

Year:  2016        PMID: 27423618     DOI: 10.1016/j.jns.2016.06.013

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  6 in total

1.  A Novel Splicing Mutation in the CSF1R Gene in a Family With Hereditary Diffuse Leukoencephalopathy With Axonal Spheroids.

Authors:  Xiaodong Yang; Pei Huang; Yuyan Tan; Qin Xiao
Journal:  Front Genet       Date:  2019-05-22       Impact factor: 4.599

2.  Three novel mutations in Chinese patients with CSF1R-related leukoencephalopathy.

Authors:  Min Chu; Dong-Xin Wang; Yue Cui; Yu Kong; Li Liu; Ke-Xin Xie; Tian-Xinyu Xia; Jing Zhang; Ran Gao; Ai-Hong Zhou; Chao-Dong Wang; Li-Yong Wu
Journal:  Ann Transl Med       Date:  2021-07

Review 3.  The Primary Microglial Leukodystrophies: A Review.

Authors:  Isidro Ferrer
Journal:  Int J Mol Sci       Date:  2022-06-06       Impact factor: 6.208

4.  Recent advances in the genetics of frontotemporal dementia.

Authors:  Daniel W Sirkis; Ethan G Geier; Luke W Bonham; Celeste M Karch; Jennifer S Yokoyama
Journal:  Curr Genet Med Rep       Date:  2019-01-30

Review 5.  Modeling CSF-1 receptor deficiency diseases - how close are we?

Authors:  Violeta Chitu; Şölen Gökhan; E Richard Stanley
Journal:  FEBS J       Date:  2021-07-05       Impact factor: 5.622

Review 6.  The Role of White Matter Dysfunction and Leukoencephalopathy/Leukodystrophy Genes in the Aetiology of Frontotemporal Dementias: Implications for Novel Approaches to Therapeutics.

Authors:  Hiu Chuen Lok; John B Kwok
Journal:  Int J Mol Sci       Date:  2021-03-03       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.